|

EMERGENT BIOSOLUTIONS INC (EBS)

US29089Q1058 - Common Stock

2.595  +0.2 (+8.13%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-6-30)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-608.00M-223.80M230.90M305.10M54.50M
Depreciation Amortization
135.40M143.30M123.80M114.50M110.70M
Income Taxes - Deferred
-31.80M-19.00M46.90M-2.40M-1.10M
Change In Working Capital
-82.50M500.00K-156.40M8.80M-42.40M
Interest Paid
57.00M33.00M30.40M21.00M34.50M
Taxes Paid
13.10M6.20M71.60M109.30M30.80M
Other non cash items
307.30M64.90M75.90M110.00M66.30M
OPERATING CASH FLOW
-279.60M-34.10M321.10M536.00M188.00M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
-322.80M-359.50M-225.00M-151.00M-96.90M
Other Investing Activity
N/A-21.80MN/AN/A0.00
INVESTING CASH FLOW
-74.40M-381.30M-225.00M-151.00M-96.90M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
76.50M564.20M-35.90M62.90M13.70M
Stock Issued/Repurchased
8.00M-82.10M-106.00M31.60M8.20M
Other Financing Activity
500.00K-900.00K900.00K-25.00M-57.80M
FINANCING CASH FLOW
85.00M481.20M-141.00M69.50M-35.90M
 
Exchange Rate Effect
-700.00K500.00K-300.00K-1.00M400.00K
CHANGE IN CASH
-269.70M66.30M-45.20M453.50M55.60M
 
FREE CASH FLOW
Operating Cash Flow
-279.60M-34.10M321.10M536.00M188.00M
Capital Expenditure
-322.80M-359.50M-225.00M-151.00M-96.90M
FREE CASH FLOW
-602.40M-393.60M96.10M385.00M91.10M

All data in USD

Charts